BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23226362)

  • 1. Contribution of stochastic partitioning at human embryonic stem cell division to NANOG heterogeneity.
    Wu J; Tzanakakis ES
    PLoS One; 2012; 7(11):e50715. PubMed ID: 23226362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct allelic patterns of nanog expression impart embryonic stem cell population heterogeneity.
    Wu J; Tzanakakis ES
    PLoS Comput Biol; 2013; 9(7):e1003140. PubMed ID: 23874182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stochastic NANOG fluctuations allow mouse embryonic stem cells to explore pluripotency.
    Abranches E; Guedes AM; Moravec M; Maamar H; Svoboda P; Raj A; Henrique D
    Development; 2014 Jul; 141(14):2770-9. PubMed ID: 25005472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stochastic promoter activation affects Nanog expression variability in mouse embryonic stem cells.
    Ochiai H; Sugawara T; Sakuma T; Yamamoto T
    Sci Rep; 2014 Nov; 4():7125. PubMed ID: 25410303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanog variability and pluripotency regulation of embryonic stem cells--insights from a mathematical model analysis.
    Glauche I; Herberg M; Roeder I
    PLoS One; 2010 Jun; 5(6):e11238. PubMed ID: 20574542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterning pluripotency in embryonic stem cells.
    Zhang YS; Sevilla A; Wan LQ; Lemischka IR; Vunjak-Novakovic G
    Stem Cells; 2013 Sep; 31(9):1806-15. PubMed ID: 23843329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanog safeguards pluripotency and mediates germline development.
    Chambers I; Silva J; Colby D; Nichols J; Nijmeijer B; Robertson M; Vrana J; Jones K; Grotewold L; Smith A
    Nature; 2007 Dec; 450(7173):1230-4. PubMed ID: 18097409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factor heterogeneity in pluripotent stem cells: a stochastic advantage.
    Torres-Padilla ME; Chambers I
    Development; 2014 Jun; 141(11):2173-81. PubMed ID: 24866112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells.
    Kalmar T; Lim C; Hayward P; Muñoz-Descalzo S; Nichols J; Garcia-Ojalvo J; Martinez Arias A
    PLoS Biol; 2009 Jul; 7(7):e1000149. PubMed ID: 19582141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conserved long noncoding RNAs transcriptionally regulated by Oct4 and Nanog modulate pluripotency in mouse embryonic stem cells.
    Sheik Mohamed J; Gaughwin PM; Lim B; Robson P; Lipovich L
    RNA; 2010 Feb; 16(2):324-37. PubMed ID: 20026622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative transcription factor analysis of undifferentiated single human embryonic stem cells.
    Ståhlberg A; Bengtsson M; Hemberg M; Semb H
    Clin Chem; 2009 Dec; 55(12):2162-70. PubMed ID: 19815608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion protein expression regulates embryonic stem cell pluripotency and differentiation.
    Miranda A; Pericuesta E; Ramírez MÁ; Gutierrez-Adan A
    PLoS One; 2011 Apr; 6(4):e18422. PubMed ID: 21483752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells.
    Choi SC; Choi JH; Park CY; Ahn CM; Hong SJ; Lim DS
    J Cell Physiol; 2012 Nov; 227(11):3678-92. PubMed ID: 22378194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passaging techniques and ROCK inhibitor exert reversible effects on morphology and pluripotency marker gene expression of human embryonic stem cell lines.
    Holm F; Nikdin H; Kjartansdóttir KR; Gaudenzi G; Fried K; Aspenström P; Hermanson O; Bergström-Tengzelius R
    Stem Cells Dev; 2013 Jul; 22(13):1883-92. PubMed ID: 23421967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network plasticity of pluripotency transcription factors in embryonic stem cells.
    Filipczyk A; Marr C; Hastreiter S; Feigelman J; Schwarzfischer M; Hoppe PS; Loeffler D; Kokkaliaris KD; Endele M; Schauberger B; Hilsenbeck O; Skylaki S; Hasenauer J; Anastassiadis K; Theis FJ; Schroeder T
    Nat Cell Biol; 2015 Oct; 17(10):1235-46. PubMed ID: 26389663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NANOG reporter cell lines generated by gene targeting in human embryonic stem cells.
    Fischer Y; Ganic E; Ameri J; Xian X; Johannesson M; Semb H
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and molecular characterization of the role of CTCF in human embryonic stem cell biology.
    Balakrishnan SK; Witcher M; Berggren TW; Emerson BM
    PLoS One; 2012; 7(8):e42424. PubMed ID: 22879976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based discovery of NANOG variant with enhanced properties to promote self-renewal and reprogramming of pluripotent stem cells.
    Hayashi Y; Caboni L; Das D; Yumoto F; Clayton T; Deller MC; Nguyen P; Farr CL; Chiu HJ; Miller MD; Elsliger MA; Deacon AM; Godzik A; Lesley SA; Tomoda K; Conklin BR; Wilson IA; Yamanaka S; Fletterick RJ
    Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4666-71. PubMed ID: 25825768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of genes regulated by nanog which is involved in ES cells pluripotency and early differentiation.
    Liu N; Feng X; Fang Z; Ma F; Lu S; Lu M; Han Z
    J Cell Biochem; 2008 Aug; 104(6):2348-62. PubMed ID: 18442017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells.
    Chambers I; Colby D; Robertson M; Nichols J; Lee S; Tweedie S; Smith A
    Cell; 2003 May; 113(5):643-55. PubMed ID: 12787505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.